Recordati SpA (MIL:REC) Retained Earnings : €2,148 Mil (As of Sep. 2024)

View and export this data going back to 1984. Start your Free Trial

What is Recordati SpA Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Recordati SpA's retained earnings for the quarter that ended in Sep. 2024 was €2,148 Mil.

Recordati SpA's quarterly retained earnings declined from Mar. 2024 (€2,162 Mil) to Jun. 2024 (€2,025 Mil) but then increased from Jun. 2024 (€2,025 Mil) to Sep. 2024 (€2,148 Mil).

Recordati SpA's annual retained earnings increased from Dec. 2021 (€1,662 Mil) to Dec. 2022 (€1,836 Mil) and increased from Dec. 2022 (€1,836 Mil) to Dec. 2023 (€2,026 Mil).

Recordati SpA Retained Earnings Historical Data

The historical data trend for Recordati SpA's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Retained Earnings Chart

Recordati SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

1,368.53

1,506.04

1,661.93

1,836.44

2,025.67

Recordati SpA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Retained Earnings	Get a 7-Day Free Trial															1,937.99	2,025.67	2,161.64	2,025.45	2,148.40

Recordati SpA Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Recordati SpA (MIL:REC) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Recordati SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (MIL:REC) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

RICFY:USA RECm:UK 0KBS:UK RER1:Germany RER1:Germany REC:Austria

Address

Via Matteo Civitali 1, MIlan, ITA, 20148

Website

https://www.recordati.com

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.